drugset / Trial / NCT00073164
Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the 14-day and 12-week safety and efficacy of Depakote ER used in combination with either olanzapine or risperidone versus antipsychotic monotherapy with olanzapine or risperidone for the treatment of schizophrenia.
Timeline
- Start
- 2003-07
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Divalproex Sodium | Small molecule | — | — |
| Subject | Olanzapine | Small molecule | — | — |
| Subject | Risperidone | Other / unclassified | — | — |